The role of the immune response in MULV-induced lymphomagenesis

Leukemia

Volumn 10, Issue 12, 1996, Pages 1860-1866

  Marshall, D J ^a   Gaulton, G N ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b 545 CRB ^*  (United States)

Author keywords

Immune response; Leukemogenesis; Murine leukemia virus; Thymus

Indexed keywords

VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER IMMUNOLOGY; IMMUNE RESPONSE; LYMPHOMA; MOUSE; MURINE LEUKEMIA VIRUS; NEWBORN; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; THYMUS; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS REPLICATION;

EID: 0030461577     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Chesebro B, Wehrly K. Studies on the role of the host immune response in recovery from Friend virus leukemia. I. Antiviral and antileukemia cell antibodies. J Exp Med 1976; 143: 73-84.
2. Chesebro B, Wehrly K. Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity. J Exp Med 1976; 143: 84-99.
3. Plata F, Langlade-Demoyen P, Abastado JP, Berbar T, Kourilsky P. Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo. Cell 1987; 48: 231-240.
4. Plata F, Langlade-Demoyen P, Abastado JP, Berbar T, Kourilsky P. Molecular definition of retrovirus-induced antigens recognized by tumour-specific H-2 restricted cytolytic T lymphocytes. J Immunogenet 1986; 13: 263-268.
5. Holt CA, Osorio K, Lilly F. Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities. J Exp Med 1986; 164: 211-226.
6. Zanovello P, Collavo D, Ronchese F, De Rossi A, Biasi G, Chieco-Bianchi L. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukemia virus (M-MuL V). Virology 1984; 51: 9-16.
7. Saha K, Wong PKY. Protective role of cytotoxic lymphocytes against murine leukemia virus-induced neurologic disease and immunodeficiency is enhanced by the presence of helper T cells. Virology 1992; 188: 921-925.
8. Cerundolo V, Lahave T, Horvath C, Zanovello P, Collavo D, Engers HD. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone, Eur J Immunol 1987; 17: 173-178.
9. + T cells in vivo. J Immunol 1989; 142: 4435-4440.
10. Tumas K, Overmoyer B, Clevenger CV, Blank KJ, Prystowsky MB. Murine leukemia virus infection in immunocompetent adult mice. Virology 1993; 192: 1-10.
11. Allison AC, Law LW. Effects of antilymphocyte serum on virus oncogenesis. Proc Soc Exp Biol, NY 1968; 127: 207-212.
12. Vredevoe DL, Hays EF. Effect of antilymphocyte and antithymocytic sera on the development of mouse lymphoma. Cancer Res 1969; 29: 1685-1690.
13. Van der Caag HC, Axelrad AA. Friend virus replication in normal and immunosuppressed C57BL/6 mice. Virology 1990; 177: 837-839.
14. Nazarov V, Hilbert D, Wolff L. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia. Virology 1994; 205: 479-485.
15. Blank KJ, Freedman HA, Lilly F. T-lymphocyte response to friend virus-induced tumour cell lines in mice of strains congenic at H-2. Nature 1976; 260: 250-252.
16. Cross L. 'Spontaneous' leukemia developing in C3H mice following inoculation, in infancy, with AK-leukemic extracts, or AK-embryos. Proc Soc Exp Biol NY 1951; 76: 27-32.
17. Moloney JB. Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations. J Natl Cancer Inst 1960; 24: 933-947.
18. Gross L. Development and serial cell-free passage of a highly potent strain of mouse leukemia virus. Proc Soc Exp Biol NY 1957; 94: 767-771.
19. Lieberman M. Some factors in the induction of lymphoid tumors by intrathymic inoculation of RLV (radiation leukemia virus). Proc Am Assoc Cancer Res 1967; 8: 41.
20. Korostoff JM, Nakada MT, Faas SJ, Blank KJ, Gaulton GN. Neonatal exposure to thymotropic gross murine leukemia virus induces virus-specific immunologic nonresponsiveness. J Exp Med 1990; 172: 1765-1775.
21. Korostoff JM, Nakada MT, Markman JF, Gaulton GN. Impaired immune responsiveness is an essential component in persistent central nervous system infection with gross murine leukemia virus. ; Neuroimmunol 1991; 34: 1-14.
22. Hein A, Czub S, Xiao LX, Schwender S, Dorries R, Czub M. Effects of adoptive transfers on murine leukemia virus-infection of rats. Virology 1995; 211: 408-417.
23. Ceglowski WS, Friedman H. Immunosuppressive effects of Friend and Rauscher leukemia disease viruses on cellular and humoral antibody formation. J Natl Cancer Inst 1968; 40: 983-995.
24. Collavo D, Zanovello P, Biasi G, Chieco-Bianchi L. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice. J Immunol 1981; 126: 187-193.
25. Peled A, Haran-Ghera N. Immunosuppression by the radiation leukemia virus and its relation to lymphatic leukemia development, Int J Cancer 1971; 8: 97-106.
26. Collavo D, Ronchese F, Zanovello P, Biasi G, Chieco-Bianchi L. T cell tolerance in Moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors. J Immunol 1982; 128: 774-779.
27. Ceglowski WS, Friedman H. Murine virus leukaemogenesis: relationship between susceptibility and imrnunodepression. Nature 1969; 224: 1318-1319.
28. Peterson RDA, Hendrickson R, Good RA. Reduced antibody forming capacity during the incubation period of passage A leukemia in C3H mice. Proc Soc Exp Biol NY 1963; 114: 517-519.
29. Sarzotti M, Robbins DS, Hoffman PM. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 1996; 271: 1726-1728.
30. Haraguchi S, Good RA, Cianciolo GJ, Day NK. A synthetic peptide homologous to retroviral envelope protein down-regulates TNF-alpha and IFN-gamma mRNA expression. J Leuk Biol 1992; 52: 469-472.
31. Haraguchi S, Good RA, James-Yarish M, Cianciolo GJ, Day NK. Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proc Natl Acad Sci USA 1995; 92: 3611-3615.
32. Haraguchi S, Good RA, James-Yarish M, Cianciolo GJ, Day NK. Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections. Proc Natl Acad Sci USA 1995; 92: 5568-5571.
33. Wolfe JH, Blank KJ. Identification of a variant of Gross leukemia virus that induces disease in mice inoculated as adults. J Exp Med 1983; 158: 629-634.
34. Tumas KM, Poszgay JM, Avidan N, Ksiazek SJ, Overmoyer B, Blank KJ, Prystowsky MB. Loss of antigenic epitopes as the result of env gene recombination in retrovirus-induced leukemia in immunocompetent mice. Virology 1993; 192: 587-595.
35. Fischinger PJ, Nomura S, Bolognesi DP. A novel murine oncorna-virus with dual eco- and xenotropic properties. Proc Natl Acad Sd USA 1975; 72: 5150-5155.
36. Hartley JW, Wolford NK, Old LJ, Rowe WP. A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc Natl Acad Sci USA 1977; 74: 789-792.
37. Nowinski RC, Doyle T. Cellular changes in the thymuses of preleukemic AKR mice: correlation with changes in the expression of murine leukemia viruses. Cell 1977; 12: 342-353.
38. Evans LH, Cloyd MW. Generation of mink cell focus-forming viruses by Friend murine leukemia virus: recombination with specific endogenous proviral sequences. J Virol 1984; 49: 772-781.
39. Lavignon M, Evans L. A multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference. J Virol 1996; 70: 3852-3862.
40. Krieg AM, Gause WC, Gourley MF, Steinberg AD. A role for endogenous retroviral sequences in the regulation of lymphocyte activation. J Immunol 1989; 143: 2448-2451.
41. Ruscetti S, Davis L, Feild J, Oliff A. Friend murine leukemia virus-induced leukemia is associated with the formation of mink cell focus-inducing viruses and is blocked in mice expressing endogenous mink cell focus-inducing xenotropic viral envelope genes. J Exp Med 1981; 154: 907-920.
42. Pozsgay JM, Klyczek KK, Blank KJ. In vivo generation of antigenic variants of murine retroviruses. Virology 1989; 173: 330-334.
43. Dent PB, Peterson RDA, Good RA. A defect in cellular immunity during the incubation period of passage A leukemia in C3H mice. Proc Soc Exp Biol NY 1965; 119: 869-871.
44. Schmidt DM, Sidhu NK, Cianciolo GJ, Snyderman R. Recombinant hydrophilic region of murine retroviral protein p15E inhibits stimulated T-lymphocyte proliferation. Proc Natl Acad Sci USA 1987; 84: 7290-7294.
45. Cianciolo GJ, Matthews TJ, Bolgnesi GP, Snyderman R. Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses. J Immunol 1980; 124: 2900-2905.
46. Levy MH, Wheelock EF. The role of macrophages in defense against neoplastic diseases. Adv Cancer Res 1974; 20: 131-163.
47. Cianciolo GJ, Lostrom ME, Tam M, Snyderman R. Murine malignant cells synthesize a 19000-dalton protein that is physiochemically and antigenically related to the immunosuppressive retroviral protein, p15E. J Exp Med 1983; 158: 885-900.
48. Cianciolo GJ. Inhibition of lymphocyte proliferation by a synthetic peptide corresponding to a region of transforming growth factor beta homologous to CKS-17, an immunosuppressive retroviral-related peptide. Clin Res 1990; 38: 325a.
49. Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 1985; 230: 453-455.
50. Goodenow RS, Vogel JM, Linsk RL. Histocompatibility antigens on murine tumors. Science 1985; 230: 777-783.
51. Festenstein H, Schmidt W. Variation in MHC antigenic profiles of tumor cells and its biological effects, Immunol Rev 1981; 60: 85-127.
52. Schmidt W, Festenstein H. Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia, Immunogenetics 1982; 16: 257-264.
53. Biasi G, Collavo D, Chieco-Bianchi L. Selective failure of accessory cell function in Moloney murine leukemia virus-tolerant mice. J Immunol 1983; 131: 16-18.
54. Gross L. Effect of thymectomy on development of leukemia in C3H mice inoculated with leukemic 'passage' virus. Proc Soc Exp Biol NY 1959; 100: 325-328.
55. McEndy DP, Boon MC, Furth J. On the role of the thymus, spleen, and gonads in the development of leukemia in a high-leukemia stock of mice. Cancer Res 1944; 4: 377-383.
56. Miller JFAP. Studies on mouse leukaemia. The role of the thymus in leukaernogenesis by cell-free leukaemic filtrates. Br J Cancer 1960; 14: 93-98.
57. Kaplan HS. Leukemia and lymphorna in experimental and domestic animals. Serol Haematol 1974; 7: 94-163.
58. Decleve A, Travis M, Weissman IL, Lieberman M, Kaplan HS. Focal infection and transformation in situ of thymus cell subclasses by a thymotropic murine leukemia virus. Cancer Res 1975; 35: 3585-3595.
59. Kaplan HS, Lieberman M. The role of lymphoid and haematopoietic target cells in viral lymphomagenesis of C57BL/Ka mice. II. Neoplastic transformation of bone marrow-derived cells in the thymic microenvironment. Blood Cells 1976; 2: 301-317.
60. Alam AM, Travers PJ, Wung JL, Nasholds W, Redpath S, Jameson S, Gascoigne NRJ. T cell receptor affinity and thymocyte positive selection. Nature 1996; 381: 616-620.
61. Blackman M, Kappler J, Marrack P. The role of the TCR in positive and negative selection of developing cells. Science 1990; 248: 1335-1341.
62. Marrack P, Kappler J. T cell tolerance. Semin Immunol 1990; 2: 45-63.
63. Bendelac A, Matzinger P, Seder RA, Paul WE, Schwartz RH. Activation events during thymic selection. J Exp Med 1992; 175: 731-742.
64. Anderson G, Owen JJT, Moore NC, Jenkinson EJ. Characteristics of an in vitro system of thymocyte positive selection. J Immunol 1994; 153: 1915-1920.
65. Axelrad AA, van der Gaag HC. Susceptibility to lymphoma induction by Gross' passage A virus in C3H/Bi mice of different ages: relation to thymic cell multiplication and differentiation, J Natl Cancer Inst 1962; 28: 1065-1093.
66. Haran-Ghera N, Lieberman M, Kaplan HS. Direct action of a leukemogenic virus on the thymus. Cancer Res 1966; 26: 438-442.
67. Scollay R, Jacobs S, Jerabek L, Butcher E, Weissman I. T cell maturation: thymocyte and thymus migrant subpopulations defined with monoclonal antibodies to MHC region antigens, J Immunol 1980; 124: 2845-2853.
68. de Harven E. Virus particles in the thymus of conventional and germfree mice. J Exp Med 1964; 120: 857-868.
69. Marshall DJ, Park BH, Korostoff JM, Gaulton GN. Manipulation of the immune response by foreign gene expression in the thymus. Leukemia 1995; 9: S128-S132.
70. Hays EF. Irradiation and viral lymphomagenesis in thymic grafts. J Natl Cancer Inst 1973; 50: 523-528.
71. Haas M. Genetic analysis of in vitro leukemogenesis induced by thymus epithelial reticulum cells transmitting murine leukemia viruses, Int J Cancer 1978; 21: 115-120.
72. Waksal SD, Smolinsky S, Cohen IR, Feldman M. Transformation of thymocytes by thymus epithelium derived from AKR mice. Nature 1976; 263: 512-514.
73. Hays EF, Bristol GC, McDougall S, Klotz JL, Kronenberg M. Development of lymphoma in the thymus of AKR mice treated with the lymphomagenic virus SL3-3. Cancer Res 1989; 49: 4225-4230.
74. Jamieson BD, Ahmed R. T cell tolerance: exposure to virus in utero does not cause a permanent deletion of specific T cells. Proc Natl Acad Sci USA 1988; 85: 2265-2268.
75. Robey E, Fowlkes BJ. Selective events in T cell development. Ann Rev Immunol 1994; 12: 675-705.
76. Collavo D, Ronchese F, Zanovello P, Cerundolo V, Biasi G. Reduction in precursors of cytotoxic T lymphocytes and of cells with natural killer-like activity in spleen of cyclophosphamide-treated mice, Int J Immunopharmacol 1985; 6: 529-535.
77. Carnes WH, Lieberman M, Marchildon M, Kaplan HS. Electron micrograph demonstration of C57BL mouse lymphoma virus (RLV). Fed Proc 1966; 25: 478.
78. Hays EF, Bristol G, McDougall S. Mechanisms of thymic lymphomagenesis by the retrovirus SL3-3. Cancer Res 1990; 50: 5631S-5635S.
79. Hays EF, Bristol GC, Lugo JP, Wang XF. Progression to development of lymphoma in the thymus of AKR mice treated neonatally with SL3-3 virus, Exp Hematol 1989; 17: 1116-1121.